A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development. (Q37092813)

From Wikidata
Jump to navigation Jump to search
scientific article published on 05 December 2007
edit
Language Label Description Also known as
English
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.
scientific article published on 05 December 2007

    Statements

    A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit